Generate a tailored SOP for Dr. Maréne Landström. Improve your application with a focused, well-structured draft.
Maréne Landström is a Professor in the Department of Pathology at Umeå University. Her research focuses on developing new cancer drugs and predictive biomarkers for aggressive cancers, utilizing advanced techniques such as CRISPR/Cas9. She investigates the roles of transforming growth factor beta (TGFb), Wnt3a, and various growth factors in activating molecular mechanisms related to prostate and kidney cancers. Her work employs a combination of in vitro and in vivo models as well as clinical materials from patients to understand the progression and metastatic potential of these cancers. Aiming to develop effective treatments, Landström leads collaborative projects with the SciLifeLab Drug Discovery Development platform. She has contributed to significant discoveries within the field, including novel insights into the prognostic factors of cancer patients and the crosstalk of signaling pathways in cancer progression.
Requirements are standard for Master's programs across Social Sciences and Humanities at Umeå. English 6 proficiency is the general rule.